Table of Contents Table of Contents
Previous Page  51 / 56 Next Page
Information
Show Menu
Previous Page 51 / 56 Next Page
Page Background

51

Satellite Symposia

ThurSday, 20 April 2017

SA-01

Industry Sponsored Session

17:45–19:15

Ballroom A

Costing adult ADHD

Chair: Andreas Reif, Germany

Getting to the real cost of ADHD: Comparing adults

to their siblings

David Daley, UK, Anne-Mette Lange, Denmark

Supported by an unrestricted grant from MEDICE

Arzneimittel Pütter GmbH & Co KG

Friday, 21 April 2017

SA-02

Industry Sponsored Session

12:15–13:30

East Meetingroom 1/2/3

Sustaining the optimal management of ADHD in

children and adolescents

Chairman’s introduction

Kenny Handelman, Canada

What can we learn about optimal management of

ADHD from the MTA study?

Peter Jensen, USA

Achieving and sustaining optimal management of

ADHD in children and adolescents

David Coghill, Australia

Ask the Experts – Panel discussion forum

Panel moderator: Duncan Manders, UK

Panellists: David Coghill, Australia

Kenny Handelman, Canada

Peter Jensen, USA

Javier Quintero, Spain

Luis Rohde, Brazil

Chairman’s closing comments

Kenny Handelman, Canada

Supported by an unrestricted educational grant from

Shire International GmbH

SA-03

Industry Sponsored Session

13:30–14:30

East Meetingroom 11/12

Can the Newest Research in ADHD Translate into

Better Patient Outcomes? A case based examination

Chair: Martin Katzman, Canada

Treatment of adult ADHD: A non-pharmacologic

perspective

Timothy Bilkey, Canada

Neurobiology to stratify patient presentation and

management

Martin Katzman, Canada

Latest functional measures and how they can be used

in the clinic

Angelo Fallu, Canada

Supported by an unrestricted grant from PURDUE

Saturday, 22 April 2017

SA-04

Industry Sponsored Session

12:45–14:00

East Meetingroom 1/2/3

Recognising, diagnosing and treating ADHD in adults

Chairman’s introduction

Martin Katzman, Canada

Understanding ADHD across the lifespan

Hugh Morgan, Australia

Differential diagnosis of comorbid ADHD

Larry Klassen, Canada

How should we optimally treat ADHD in adults?

Joel Young, USA

Question time

All

Chairman’s closing comments

Martin Katzman, Canada

Supported by an unrestricted educational grant from

Shire International GmbH